Second Opinion in Pharmacotherapy of ADHD: Do Not Postpone It!

Clin Ther. 2022 Jun;44(6):924-925. doi: 10.1016/j.clinthera.2022.04.003. Epub 2022 Apr 29.

Author

Affiliation

¹ Regional Medicines Information and Pharmacovigilance Centre (RELIS Vest), and the Department of Clinical Biochemistry and Pharmacology, Haukeland University Hospital; and the Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.

PMID: 35501175
DOI: 10.1016/j.clinthera.2022.04.003

No abstract available

Publication types

Letter

MeSH terms

Attention Deficit Disorder with Hyperactivity* / drug therapy
Central Nervous System Stimulants* / adverse effects
Humans
Referral and Consultation

Substances

Central Nervous System Stimulants